Abstract: Slide Presentations |

Dante: A Randomised Trial on Early Diagnosis of Lung Cancer With Low-dose Spiral CT (LDCT); Initial Announcement FREE TO VIEW

Maurizio V. Infante, MD; Fabio R. Lutman, MD; Silvio Cavuto, PhD; Giorgio Brambilla, MD; Umberto Cariboni, MD; Marco Alloisio, MD; Alberto Testori, MD; Matteo Incarbone, MD; Massimo Roncalli, MD, PhD; Gianluigi Ravasi, MD
Author and Funding Information

Humanitas Hospital, Milano, Italy


Chest. 2003;124(4_MeetingAbstracts):118S-c-119S. doi:10.1378/chest.124.4_MeetingAbstracts.118S-c
Text Size: A A A
Published online


PURPOSE:  To determine the efficacy of lung cancer screening with low-dose CT on LC mortality. LC prevalence, incidence, stage distribution, and resectability are secondary endpoints.To investigate the prevalence of a set of genetic mutations in sputum and blood samples of heavy smokers

METHODS:  2400 pts will be randomised and followed for at least 5 years. Inclusion criteria are male sex, age 60–75, smoking history of 20+ pack-years.On accrual, all subjects undergo clinical examination, Chest X-rays (CXR) and sputum cytology. Blood and sputum samples are also collected for genetic analyses. Screened subjects undergo immediate LDCT, repeated annually. Controls undergo yearly clinical examination. Positive CXR cases are screened out.

RESULTS:  As of March 11, 2003, 786 subjects have been randomised. Their mean age is 65 and 60% are currently active smokers. Hypertension, COPD and cardiovascular diseases are the most prevalent comorbidities. Age distribution, comorbidities, and smoking history are comparable between the two groups. The preliminary results are summarized in Table 1

Preliminary results at two years

BASELINELDCTCtrlsOverallN°414372786Pts with Non-Calcified Lesions45 (11%)Follow-up LDCTs12517FNABs437VATS415Open Biopsy202LC detected9 (2.17%)4 (1.01%)13Negative CXR5R0 resection6 (67%)3 (75%).1 LC patient in the screened group had negative LDCT but positive sputum examination.1 low-symptomatic esophageal cancer, one aspergilloma and one esophageal leiomyoma were incidentally diagnosed by LDCT.CONCLUSIONS: The workup of doubtful or suspicious lesions resulted in a more extensive use of semi-invasive or invasive investigations in the LDCT group. There have been more LC cases detected through LDCT than with CXR, but the numbers are still small. Accrual is ongoing.

CLINICAL IMPLICATIONS:  Several LC screening programmes with LDCT are currently active and report on high rates of early-stage lung cancer detection. Concerns about possible biases influencing survival outcomes in uncontrolled studies, added morbidity due to follow-up investigations and health resources burden warrant further investigation through randomized controlled trials.

DISCLOSURE:  M.V. Infante, None.

Tuesday, October 28, 2003

2:30 PM - 4:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543